Amanda Mathis
BioCryst Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Trypanosoma species research and implications, Viral Infections and Vectors, Mosquito-borne diseases and control
Most-Cited Works
- → Antiparasitic compounds that target DNA(2008)214 cited
- → Dications That Target the DNA Minor Groove: Compound Design and Preparation, DNA Interactions, Cellular Distribution and Biological Activity(2005)172 cited
- → Accumulation and Intracellular Distribution of Antitrypanosomal Diamidine Compounds DB75 and DB820 in African Trypanosomes(2006)120 cited
- → An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral(2021)77 cited
- → Diphenyl Furans and Aza Analogs: Effects of Structural Modification on In Vitro Activity, DNA Binding, and Accumulation and Distribution in Trypanosomes(2007)72 cited
- → Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters(2018)72 cited
- → Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents(2013)67 cited
- → Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase(2013)55 cited
- → Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase(2012)54 cited
- → Design of N -Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor(2019)54 cited